What you need to know about the heightened competition in the home improvement business.
A shaky housing market is tempering Wall Street optimism on the retail giant.
The home improvement giant could surprise on the upside, but the bigger risk is if Home Depot closes below the April and October lows.
Alibaba investors might have a lonely feeling on Friday.
Alibaba's real investment thesis might be in the cloud.
Alibaba's Singles Day is the biggest day for retail by far.
The trade temperature is only heating up.
With a stock like Alibaba it is important that it proves itself before you put your hard-earned money at risk.
All the lonely people can't lift Alibaba.
It's unclear whether the low will hold or if shares of China's online commerce giant will slide further.
Disney stock is getting a bump after earnings on Thursday.
Disney's DTC push takes aim at Netflix. Which is the play?
DIS is a good value compared to most other big-cap names right now.
Disney could be in line for a breakout based on a few key factors.
Disney has a lot of variables heading into earnings.
The charts of the entertainment giant indicate its stock is ready to break out any day now.
Consumer Discretionary stocks were the hottest on Wednesday, though all eleven sectors easily finished in the green.
Twilio rises as high as the clouds on Wednesday.
Twilio's new CFO brings a traditional business focus from his time at GE.
TWLO's continued success shows it has moved past primary partnerships.
Twilio's pending acquisition is pushing new highs.
Twilio bulls are feeling vindicated on Wednesday morning.
Eli Lilly's excellent earnings weren't excellent enough.
Eli Lilly's self-policing on drug pricing protects it from the most prominent political pushbacks.
Eli Lilly's confirmation of acquisition action could make pharmaceuticals an attractive investment space.
LLY's stock slide after earnings might present a buying opportunity.
The giant drugmaker raised its profit guidance for all of 2018 after its third-quarter results beat expectations.
It shouldn't hurt that the drugmaker beat third-quarter estimates and raised its profit guidance for all of 2018.
Marriott's miss is stinging shareholders again.
Marriott's move to make a deal comes at an opportune time. But is it enough?